Cloudbreak Therapeutics is a clinical stage biotechnology company
Cloudbreak Therapeutics has raised $130.0M in total funding. The most recent round was Series C. The last funding was announced in January 2022.
Cloudbreak Therapeutics's investors include CDH Investments, V-Capital, EFung Capital, Industrial Securities Capital, CCB International.
Cloudbreak Therapeutics is headquartered in Irvine, United States.
Cloudbreak Therapeutics is a clinical stage biotechnology company
Cloudbreak Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cloudbreak Therapeutics — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/cloudbreak-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). Cloudbreak Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/cloudbreak-therapeutics
{{cite web |title=Cloudbreak Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cloudbreak-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated